BIRC5 and cervical carcinoma: Recently, it was reported that knocking down of survivin using siRNA can enhance sensitivity to BPR0L075 in human cervical carcinoma KB cells and cause mitotic cell death; overexpression of survivin counteracts the therapeutic effect of BPR0L075 [42].